Literature DB >> 6183980

Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventricles.

S G Potkin, D R Weinberger, M Linnoila, R J Wyatt.   

Abstract

The authors assayed CSF 5-hydroxyindoleacetic acid (5-HIAA) concentrations in 24 chronic schizophrenic patients, 9 of whom had enlarged cerebral ventricles according to computerized tomography scans, and in 15 control subjects with neurological disorders. Although there were no overall differences between the schizophrenic patients and the control subjects, schizophrenic patients with enlarged ventricles had significantly lower 5-HIAA concentrations. Also, ventricular size correlated inversely with 5-HIAA concentrations. The findings are consistent with other evidence that cerebral ventricular size is biologically meaningful in schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6183980     DOI: 10.1176/ajp.140.1.21

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  3 in total

1.  Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder.

Authors:  Mary Ann Richardson; Laura L Read; Margaret A Reilly; James D Clelland; Catherine L Taylor Clelland
Journal:  Neurochem Res       Date:  2006-12-09       Impact factor: 3.996

2.  Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.

Authors:  H Beckmann; P Waldmeier; J Lauber; W F Gattaz
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 3.  The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Authors:  D C Ohuoha; T M Hyde; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.